| Brazil |
If traveling from the endemic zones listed below and >9 months of age: Africa: Angola, Benin, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Democratic Republic of Congo, Congo, Côte d’Ivoire, Ethiopia, Gabon, The Gambia, Ghana, Guinea, Guinea Bissau, Equatorial Guinea, Liberia, Mali, Mauritania, Niger, Nigeria, Kenya, Rwanda, São Tomé and Principe, Senegal, Sierra Leone, Somalia, Sudan, Tanzania, Togo, and Uganda. Americas: Bolivia, Colombia, Ecuador, Guyana, French Guiana, Peru, Surinam, and Venezuela. Central America & Caribbean: Panama, and Trinidad and Tobago. |
For all travelers >9 months of age going to the endemic zone in Brazil, which includes the states of Acre, Amapa, Amazones, Goias, Maranhao, Mato Grosso, Mato Grosso do Sul, Minas Gerais, Para, Rondonia, Roraima, and Tocantins, and areas in the endemic zone of the states of Bahia, Parana, Piaui, Rio Grande do Sul, and Sao Paulo (see Updated yellow fever risk map for Brazil). As of January 2008, the northern part of Espiritu Santo state and the western part of Santa Catarina state were also added to the yellow fever risk areas of Brazil. The Federal District of Brasilia is also an endemic area. Vaccination is recommended for travelers visiting Iguaçu Falls. Coastal cities, including Rio de Janeiro, Sao Paulo, Salvador, Recife, and Fortaleza, are NOT within the endemic zone. |
States of Acre, Rondônia, Amapá, Amazonas, Roraima, and Tocantins. Parts of states of Maranhaõ (western part), Mato Grosso (northern part), and Pará (except Belem City). There is also transmission in urban areas, including large cities such as Porto Velho, Boa Vista, Macapa, Manaus, Santarem, and Maraba, where transmission occurs on the periphery of these cities. |
Confirmed |
Atovaquone/ proguanil, doxycycline, or mefloquine |